101 related articles for article (PubMed ID: 1777423)
41. Possible role of ceramide in defining structure and function of membrane glycolipids.
Kannagi R; Nudelman E; Hakomori S
Proc Natl Acad Sci U S A; 1982 Jun; 79(11):3470-4. PubMed ID: 6954491
[TBL] [Abstract][Full Text] [Related]
42. Accumulation of highly acidic sulfated glycosphingolipids in human hepatocellular carcinoma defined by a series of monoclonal antibodies.
Hiraiwa N; Fukuda Y; Imura H; Tadano-Aritomi K; Nagai K; Ishizuka I; Kannagi R
Cancer Res; 1990 May; 50(10):2917-28. PubMed ID: 2159366
[TBL] [Abstract][Full Text] [Related]
43. Changes of glycoconjugate expression profiles during early development.
Handa K; Hakomori SI
Glycoconj J; 2017 Dec; 34(6):693-699. PubMed ID: 27318475
[TBL] [Abstract][Full Text] [Related]
44. Differential expression of CD150/SLAMF1 in normal and malignant B cells on the different stages of maturation.
Gordiienko IM; Shlapatska LM; Kovalevska LM; Sidorenko SP
Exp Oncol; 2016 Jun; 38(2):101-7. PubMed ID: 27356578
[TBL] [Abstract][Full Text] [Related]
45. Alteration of lacto-series glycolipid glycosyltransferase activities in human colonic adenocarcinoma DLD-1 cells after culture in N,N-dimethylformamide-containing medium.
Holmes EH; Greene TG
J Cell Biochem; 1990 Oct; 44(2):93-105. PubMed ID: 2250046
[TBL] [Abstract][Full Text] [Related]
46. Characteristics of two CD75-related cell-surface expressed antigens of human lymphocytes.
Eichler W
Mol Immunol; 2007 Mar; 44(8):2047-55. PubMed ID: 17067678
[TBL] [Abstract][Full Text] [Related]
47. Expression of interleukin 10 in B lymphocytes of different origin.
Finke J; Ternes P; Lange W; Mertelsmann R; Dölken G
Leukemia; 1993 Nov; 7(11):1852-7. PubMed ID: 7694007
[TBL] [Abstract][Full Text] [Related]
48. T cell-independent B cell response to self-monosialogangliosides: primary response monoclonal antibodies.
Alfonso M; Vázquez AM; Carr A; Haerslev T; Fernández LE; Lanio ME; Alvarez C; Zeuthen J; Pérez R
Hybridoma; 1995 Jun; 14(3):209-16. PubMed ID: 7590782
[TBL] [Abstract][Full Text] [Related]
49. Characterization of moose intestinal glycosphingolipids.
Johansson MM; Dedic B; Lundholm K; Branzell FB; Barone A; Benktander J; Teneberg S
Glycoconj J; 2015 Aug; 32(6):393-412. PubMed ID: 26104834
[TBL] [Abstract][Full Text] [Related]
50. The role of globo-series glycolipids in neuronal cell differentiation--a review.
Ariga T; Yu RK
Neurochem Res; 1998 Mar; 23(3):291-303. PubMed ID: 9482241
[TBL] [Abstract][Full Text] [Related]
51. Ecto-5'-nucleotidase. I. Expression in human normal and neoplastic lymphoid cell lines representing sequential stages of B-cell differentiation.
SenGupta S; Hibi T; MacKay A; Markovic V; Stein LD; Sigal N; Gelfand EW; Chechik BE
J Natl Cancer Inst; 1984 Nov; 73(5):1075-80. PubMed ID: 6092765
[TBL] [Abstract][Full Text] [Related]
52. Biosynthesis of the so-called "a" and "asialo" pathway glycosphingolipids is differentially regulated in murine myelogenous leukemia NFS60 cells.
Nakamura M; Sakai T; Furukawa Y; Kitagawa S; Sakoe K; Tsunoda A
Biochem Biophys Res Commun; 1995 Dec; 217(3):733-40. PubMed ID: 8554592
[TBL] [Abstract][Full Text] [Related]
53. Reversible G1 arrest induced by dimethyl sulfoxide in human lymphoid cell lines: dimethyl sulfoxide inhibits IL-6-induced differentiation of SKW6-CL4 into IgM-secreting plasma cells.
Teraoka H; Mikoshiba M; Takase K; Yamamoto K; Tsukada K
Exp Cell Res; 1996 Jan; 222(1):218-24. PubMed ID: 8549666
[TBL] [Abstract][Full Text] [Related]
54. EBV transformation overrides gene expression patterns of B cell differentiation stages.
Siemer D; Kurth J; Lang S; Lehnerdt G; Stanelle J; Küppers R
Mol Immunol; 2008 Jun; 45(11):3133-41. PubMed ID: 18430472
[TBL] [Abstract][Full Text] [Related]
55. B lymphoblast antigen (BB-1) expressed on Epstein-Barr virus-activated B cell blasts, B lymphoblastoid cell lines, and Burkitt's lymphomas.
Yokochi T; Holly RD; Clark EA
J Immunol; 1982 Feb; 128(2):823-7. PubMed ID: 6274961
[TBL] [Abstract][Full Text] [Related]
56. Accessory function of human leukemic cell lines: properties of B and B-K562 hybrid cell lines.
Wakasugi H; Dokhelar MC; Garson D; Harel-Bellan A; Fradelizi D; Tursz T
Eur J Immunol; 1985 Mar; 15(3):256-61. PubMed ID: 3872216
[TBL] [Abstract][Full Text] [Related]
57. A novel glycosphingolipid hydrolyzing enzyme, glycosphingolipid ceramide deacylase, which cleaves the linkage between the fatty acid and sphingosine base in glycosphingolipids.
Hirabayashi Y; Kimura M; Matsumoto M; Yamamoto K; Kadowaki S; Tochikura T
J Biochem; 1988 Jan; 103(1):1-4. PubMed ID: 3360750
[TBL] [Abstract][Full Text] [Related]
58. Differentiation-dependent sensitivity of human B-cell-derived lines to major histocompatibility complex-restricted T-cell cytotoxicity.
Torsteinsdottir S; Masucci MG; Ehlin-Henriksson B; Brautbar C; Ben Bassat H; Klein G; Klein E
Proc Natl Acad Sci U S A; 1986 Aug; 83(15):5620-4. PubMed ID: 3016710
[TBL] [Abstract][Full Text] [Related]
59. Galectin-3 interactions with glycosphingolipids.
Collins PM; Bum-Erdene K; Yu X; Blanchard H
J Mol Biol; 2014 Apr; 426(7):1439-51. PubMed ID: 24326249
[TBL] [Abstract][Full Text] [Related]
60. Immunohistological and flow cytometric analysis of glycosphingolipid expression in mouse lymphoid tissues.
Kovacic N; Müthing J; Marusic A
J Histochem Cytochem; 2000 Dec; 48(12):1677-90. PubMed ID: 11101636
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
